Envíos recientes

Mostrando ítems 1516-1520 de 11841

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

2021- Garcia-Gutiérrez, V.; Luna, A.; Alonso-Dominguez, J.M.; Estrada, N.; Boque, C.; [et al.]
Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

2022- Mosquera Orgueira, Adrián; Peleteiro Raindo, Andrés; Díaz Arias, José; Antelo Rodríguez, Beatriz; López Riñón, M.; [et al.]
Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling

2024- Mosquera Orgueira, Adrián; Krali, O.; Pérez Míguez, C.; Peleteiro Raindo, Andrés; Díaz Arias, José; [et al.]
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

2022- Luna, A.; Pérez-Lamas, L.; Boque, C.; Giraldo, P.; Xicoy, B.; [et al.]
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study

2025- Pérez-Lamas, L.; Segura Diaz, A.; García Delgado, R.; Álvarez-Larrán, A.; Senin, M.A.; [et al.]